BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8542394)

  • 1. Minireview: the herpes simplex virus amplicon--a versatile defective virus vector.
    Frenkel N; Singer O; Kwong AD
    Gene Ther; 1994; 1 Suppl 1():S40-6. PubMed ID: 8542394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
    J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The history of the HSV amplicon: from naturally occurring defective genomes to engineered amplicon vectors.
    Frenkel N
    Curr Gene Ther; 2006 Jun; 6(3):277-301. PubMed ID: 16787181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus amplicon: effect of size on replication of constructed defective genomes containing eucaryotic DNA sequences.
    Kwong AD; Frenkel N
    J Virol; 1984 Sep; 51(3):595-603. PubMed ID: 6088785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modular set of helper-dependent herpes simplex virus expression vectors.
    Strathdee CA; McLeod MR
    Mol Ther; 2000 May; 1(5 Pt 1):479-85. PubMed ID: 10933969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of two potential shuttle vectors containing herpes simplex virus defective DNA.
    Bear SE; Colberg-Poley AM; Court DL; Carter BJ; Enquist LW
    J Mol Appl Genet; 1984; 2(5):471-84. PubMed ID: 6090565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
    Berthomme H; Fournel S; Epstein AL
    Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
    Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
    Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer with herpes simplex vectors.
    Lachmann RH; Efstathiou S
    Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
    Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
    J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
    Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T
    J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
    Lee CY; Bu LX; Rennie PS; Jia WW
    Cancer Gene Ther; 2007 Jul; 14(7):652-60. PubMed ID: 17479106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of recombinant herpes simplex virus ampiicons.
    Hong Z; Kwong AD
    Methods Mol Med; 1999; 19():553-64. PubMed ID: 21374396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus-based vectors.
    Lachmann R
    Int J Exp Pathol; 2004 Oct; 85(4):177-90. PubMed ID: 15312123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector.
    Spaete RR; Frenkel N
    Cell; 1982 Aug; 30(1):295-304. PubMed ID: 6290080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus vectors for gene transfer to the nervous system.
    Goins WF; Krisky D; Marconi P; Oligino T; Ramakrishnan R; Poliani PL; Fink DJ; Glorioso JC
    J Neurovirol; 1997 May; 3 Suppl 1():S80-8. PubMed ID: 9179803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.
    Toda M; Martuza RL; Rabkin SD
    Mol Ther; 2000 Oct; 2(4):324-9. PubMed ID: 11020347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.
    Krisky DM; Marconi PC; Oligino TJ; Rouse RJ; Fink DJ; Cohen JB; Watkins SC; Glorioso JC
    Gene Ther; 1998 Nov; 5(11):1517-30. PubMed ID: 9930305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella virus DI RNAs and replicons: requirement for nonstructural proteins acting in cis for amplification by helper virus.
    Tzeng WP; Chen MH; Derdeyn CA; Frey TK
    Virology; 2001 Oct; 289(1):63-73. PubMed ID: 11601918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.